Australia's most trusted
source of pharma news
Posted 20 December 2021 AM
It's been a slow week of TGA approvals with Beximco Pharmaceuticals the sole company to register a product, adding two new generic brande names for Novartis' OTC eye drops for conjuctivitis.
The company which currently has six generic products of Novartis' medicine Zaditen on the market, registered its first copy back in 2018 under the brand name Tofen Eye Drops.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.